We are live on ! Find out more
SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$42.4M +$2.73K +45 +0%
AIM
2
ARK Investment Management
Florida
$35.1M +$7.54M +124,308 +32%
NAMA
3
Nikko Asset Management Americas
New York
$34.4M +$2.07M +34,089 +7%
Sumitomo Mitsui Trust Group
4
Sumitomo Mitsui Trust Group
Japan
$34.4M +$2.07M +34,089 +7%
AVM
5
Arch Venture Management
Illinois
$22.9M -$3.28M -54,123 -14%
FP
6
Flagship Pioneering
Massachusetts
$20.3M
BlackRock
7
BlackRock
New York
$19.8M +$720K +11,865 +4%
Vanguard Group
8
Vanguard Group
Pennsylvania
$12.4M +$8.55K +141 +0.1%
SB
9
Samsara BioCapital
California
$11.3M
DM
10
Deerfield Management
New York
$8.77M
JP Morgan Chase
11
JP Morgan Chase
New York
$6.54M +$3.19M +52,550 +125%
BBA
12
Baker Bros. Advisors
New York
$4.77M -$1.73M -28,467 -29%
State Street
13
State Street
Massachusetts
$4.72M +$52.8K +870 +1%
Millennium Management
14
Millennium Management
New York
$3.63M +$3.07M +50,681 +2,699%
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$3.47M +$163K +2,691 +6%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$3.29M +$146K +2,412 +5%
SCM
17
Sio Capital Management
New York
$3.1M +$2.72M +44,853 New
Northern Trust
18
Northern Trust
Illinois
$2.77M -$154K -2,535 -6%
PCM
19
Portolan Capital Management
Massachusetts
$2.26M +$1.98M +32,685 New
RG
20
Redmile Group
California
$1.47M -$22.3M -367,646 -95%
Charles Schwab
21
Charles Schwab
California
$1.42M +$38K +626 +3%
D.E. Shaw & Co
22
D.E. Shaw & Co
New York
$1.02M +$450K +7,414 +102%
Nuveen
23
Nuveen
North Carolina
$972K +$200K +3,299 +31%
Renaissance Technologies
24
Renaissance Technologies
New York
$892K -$955K -15,751 -55%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$770K -$667 -11 -0.1%